Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-19

Clinical Trial Update: Low Dose Versus Standard Dose Dexamethasone for Reduction of Swelling in Patients with Primary or Metastatic Brain Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial comparing low-dose versus standard-dose dexamethasone to reduce swelling in patients with malignant brain neoplasms and brain metastases; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Malignant Brain Neoplasm, Metastatic Malignant Neoplasm in the Brain | Phase 2 | Status: ACTIVE_NOT_RECRUITING